Skip to main content
Journal cover image

Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity.

Publication ,  Journal Article
Power, A; Berger, AC; Ginsburg, GS
Published in: JAMA
May 2014

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

May 2014

Volume

311

Issue

20

Start / End Page

2063 / 2064

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Translational Research, Biomedical
  • Research Support as Topic
  • National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
  • Genomics
  • General & Internal Medicine
  • Drug Repositioning
  • Drug Industry
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Power, A., Berger, A. C., & Ginsburg, G. S. (2014). Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity. JAMA, 311(20), 2063–2064. https://doi.org/10.1001/jama.2014.3002
Power, Aidan, Adam C. Berger, and Geoffrey S. Ginsburg. “Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity.JAMA 311, no. 20 (May 2014): 2063–64. https://doi.org/10.1001/jama.2014.3002.
Power A, Berger AC, Ginsburg GS. Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity. JAMA. 2014 May;311(20):2063–4.
Power, Aidan, et al. “Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity.JAMA, vol. 311, no. 20, May 2014, pp. 2063–64. Pubmed, doi:10.1001/jama.2014.3002.
Power A, Berger AC, Ginsburg GS. Genomics-enabled drug repositioning and repurposing: insights from an IOM Roundtable activity. JAMA. 2014 May;311(20):2063–2064.
Journal cover image

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

May 2014

Volume

311

Issue

20

Start / End Page

2063 / 2064

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Translational Research, Biomedical
  • Research Support as Topic
  • National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
  • Genomics
  • General & Internal Medicine
  • Drug Repositioning
  • Drug Industry
  • 42 Health sciences